Literature DB >> 23447538

Mutational tail loss is an evolutionary mechanism for liberating marapsins and other type I serine proteases from transmembrane anchors.

Kavita Raman1, Neil N Trivedi, Wilfred W Raymond, Rajkumar Ganesan, Daniel Kirchhofer, George M Verghese, Charles S Craik, Eric L Schneider, Shilpa Nimishakavi, George H Caughey.   

Abstract

Human and mouse marapsins (Prss27) are serine proteases preferentially expressed by stratified squamous epithelia. However, mouse marapsin contains a transmembrane anchor absent from the human enzyme. To gain insights into physical forms, activities, inhibition, and roles in epithelial differentiation, we traced tail loss in human marapsin to a nonsense mutation in an ancestral ape, compared substrate preferences of mouse and human marapsins with those of the epithelial peptidase prostasin, designed a selective substrate and inhibitor, and generated Prss27-null mice. Phylogenetic analysis predicts that most marapsins are transmembrane proteins. However, nonsense mutations caused membrane anchor loss in three clades: human/bonobo/chimpanzee, guinea pig/degu/tuco-tuco/mole rat, and cattle/yak. Most marapsin-related proteases, including prostasins, are type I transmembrane proteins, but the closest relatives (prosemins) are not. Soluble mouse and human marapsins are tryptic with subsite preferences distinct from those of prostasin, lack general proteinase activity, and unlike prostasins resist antiproteases, including leupeptin, aprotinin, serpins, and α2-macroglobulin, suggesting the presence of non-canonical active sites. Prss27-null mice develop normally in barrier conditions and are fertile without overt epithelial defects, indicating that marapsin does not play critical, non-redundant roles in development, reproduction, or epithelial differentiation. In conclusion, marapsins are conserved, inhibitor-resistant, tryptic peptidases. Although marapsins are type I transmembrane proteins in their typical form, they mutated independently into anchorless forms in several mammalian clades, including one involving humans. Similar pathways appear to have been traversed by prosemins and tryptases, suggesting that mutational tail loss is an important means of evolving new functions of tryptic serine proteases from transmembrane ancestors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23447538      PMCID: PMC3624440          DOI: 10.1074/jbc.M112.449033

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  On filtering false positive transmembrane protein predictions.

Authors:  Miklos Cserzö; Frank Eisenhaber; Birgit Eisenhaber; Istvan Simon
Journal:  Protein Eng       Date:  2002-09

2.  Prostasin is a glycosylphosphatidylinositol-anchored active serine protease.

Authors:  L M Chen; M L Skinner; S W Kauffman; J Chao; L Chao; C D Thaler; K X Chai
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

3.  Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice.

Authors:  P J Wolters; C T Pham; D J Muilenburg; T J Ley; G H Caughey
Journal:  J Biol Chem       Date:  2001-02-23       Impact factor: 5.157

4.  A despecialization step underlying evolution of a family of serine proteases.

Authors:  Merridee A Wouters; Ke Liu; Peter Riek; Ahsan Husain
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

5.  Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.

Authors:  G H Caughey; W W Raymond; J L Blount; L W Hau; M Pallaoro; P J Wolters; G M Verghese
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

6.  Human tryptase epsilon (PRSS22), a new member of the chromosome 16p13.3 family of human serine proteases expressed in airway epithelial cells.

Authors:  G W Wong; S Yasuda; M S Madhusudhan; L Li; Y Yang; S A Krilis; A Sali; R L Stevens
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

Review 7.  Human and mouse proteases: a comparative genomic approach.

Authors:  Xose S Puente; Luis M Sánchez; Christopher M Overall; Carlos López-Otín
Journal:  Nat Rev Genet       Date:  2003-07       Impact factor: 53.242

Review 8.  Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer.

Authors:  Sarah Netzel-Arnett; John D Hooper; Roman Szabo; Edwin L Madison; James P Quigley; Thomas H Bugge; Toni M Antalis
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

9.  Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas.

Authors:  Vikash J Bhagwandin; Leola W-T Hau; Jon Mallen-St Clair; Paul J Wolters; George H Caughey
Journal:  J Biol Chem       Date:  2002-11-18       Impact factor: 5.157

10.  Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site.

Authors:  Wilfred W Raymond; Sandra Waugh Ruggles; Charles S Craik; George H Caughey
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

View more
  2 in total

Review 1.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

2.  The testis-specific serine proteases PRSS44, PRSS46, and PRSS54 are dispensable for male mouse fertility†.

Authors:  Richard J Holcomb; Seiya Oura; Kaori Nozawa; Katarzyna Kent; Zhifeng Yu; Matthew J Robertson; Cristian Coarfa; Martin M Matzuk; Masahito Ikawa; Thomas X Garcia
Journal:  Biol Reprod       Date:  2020-02-12       Impact factor: 4.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.